DENVER--(BUSINESS WIRE)--Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, today announced results for its first quarter, fiscal year 2007 ended September 30, 2006. The Company recorded net revenues of $2.1 million and a loss of $(820,208), or $(0.04) per share. In the prior quarterly period, the company recorded net revenues of $1.1 million and a loss of $(1.6) million, or $(0.07) per share. For the same period in 2005, the company recorded net revenues of $3.0 million and income of $80,315.
